Ischemic Heart Disease (IHD) remains the world’s leading cause of morbidity and mortality. Despite advances in medical and surgical interventions, many patients still experience irreversible myocardial damage due to inadequate regeneration of cardiac tissue. This limitation has driven the global scientific community toward cell-based regenerative therapies, particularly mesenchymal stem cell (MSC) therapy, as a novel strategy to restore […]
Search Diseases & Conditions....

